IL97936A - 4-substituted-2-deoxy-2,3-didehydro derivatives alpha-d-neuraminic acid their preparation and pharmaceutical compositions containing them - Google Patents

4-substituted-2-deoxy-2,3-didehydro derivatives alpha-d-neuraminic acid their preparation and pharmaceutical compositions containing them

Info

Publication number
IL97936A
IL97936A IL9793691A IL9793691A IL97936A IL 97936 A IL97936 A IL 97936A IL 9793691 A IL9793691 A IL 9793691A IL 9793691 A IL9793691 A IL 9793691A IL 97936 A IL97936 A IL 97936A
Authority
IL
Israel
Prior art keywords
compound
acetamido
glycero
galacto
tetradeoxy
Prior art date
Application number
IL9793691A
Other languages
English (en)
Original Assignee
Biota Scient Management
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scient Management filed Critical Biota Scient Management
Publication of IL97936A publication Critical patent/IL97936A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrane Compounds (AREA)
IL9793691A 1990-04-24 1991-04-24 4-substituted-2-deoxy-2,3-didehydro derivatives alpha-d-neuraminic acid their preparation and pharmaceutical compositions containing them IL97936A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPJ980090 1990-04-24
AUPK289690 1990-10-19
AUPK453791 1991-02-11

Publications (1)

Publication Number Publication Date
IL97936A true IL97936A (en) 1995-12-08

Family

ID=27157556

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9793691A IL97936A (en) 1990-04-24 1991-04-24 4-substituted-2-deoxy-2,3-didehydro derivatives alpha-d-neuraminic acid their preparation and pharmaceutical compositions containing them

Country Status (37)

Country Link
US (2) US5360817A (cs)
EP (2) EP0526543B1 (cs)
JP (1) JP2944750B2 (cs)
KR (1) KR0169496B1 (cs)
CN (3) CN1143853C (cs)
AP (1) AP249A (cs)
AT (2) ATE406358T1 (cs)
AU (2) AU7533891A (cs)
BG (1) BG62092B1 (cs)
CA (2) CA2291994C (cs)
CY (1) CY2186B1 (cs)
CZ (1) CZ288492B6 (cs)
DE (3) DE19975068I2 (cs)
DK (1) DK0526543T3 (cs)
ES (2) ES2313730T3 (cs)
FI (2) FI105478B (cs)
GR (1) GR3026225T3 (cs)
HK (1) HK1003834A1 (cs)
HU (2) HU219355B (cs)
IE (2) IE911372A1 (cs)
IL (1) IL97936A (cs)
LU (1) LU90468I2 (cs)
MY (1) MY107843A (cs)
NL (1) NL990030I2 (cs)
NO (3) NO302751B1 (cs)
NZ (1) NZ237936A (cs)
OA (1) OA09679A (cs)
PL (3) PL166918B1 (cs)
PT (1) PT97460B (cs)
RU (1) RU2119487C1 (cs)
SG (1) SG43170A1 (cs)
SI (1) SI9110745B (cs)
SK (1) SK282950B6 (cs)
UA (1) UA41252C2 (cs)
WO (1) WO1991016320A1 (cs)
YU (1) YU48741B (cs)
ZA (1) ZA913086B (cs)

Families Citing this family (135)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2081068C (en) * 1991-10-23 2005-11-29 Laurence Mark Von Itzstein Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
GB9126725D0 (en) * 1991-12-17 1992-02-12 Glaxo Group Ltd Process
GB9220327D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9220241D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9312531D0 (en) * 1993-06-17 1993-08-04 Glaxo Group Ltd Process
US5958973A (en) * 1993-09-03 1999-09-28 Gilead Sciences, Inc. Polyhydroxy benzoic acid derivatives and their use as neuraminidase inhibitors
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9400206D0 (en) * 1994-01-07 1994-03-02 Glaxo Group Ltd Chemical compound
AUPM354694A0 (en) * 1994-01-27 1994-02-17 Biota Scientific Management Pty Ltd Chemical compounds
US5453533A (en) * 1994-04-14 1995-09-26 The University Of Alabama At Birmingham Inhibitors of influenza virus neuraminidase and methods of making and using the same
US5985859A (en) * 1994-04-14 1999-11-16 The University Of Alabama Methods of inhibiting bacterial sialidase
US5627290A (en) * 1994-05-27 1997-05-06 Daikin Industries, Ltd. 2,3-didehydrosialic acid substituted with fluorine at 7-position and synthetic intermediate thereof
GB9410817D0 (en) * 1994-05-28 1994-07-20 Glaxo Group Ltd Medicaments
AUPM725794A0 (en) * 1994-08-03 1994-08-25 Biota Scientific Management Pty Ltd Chemical compounds
US5556963A (en) * 1994-08-05 1996-09-17 Oklahoma Medical Research Foundation Synthesis of 4-alkoxy-N-acetylneuraminic acid
GB9416365D0 (en) * 1994-08-12 1994-10-05 Glaxo Group Ltd Medicaments
US5512596A (en) * 1994-09-02 1996-04-30 Gilead Sciences, Inc. Aromatic compounds
US5475109A (en) * 1994-10-17 1995-12-12 Merck & Co., Inc. Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
CN101143859A (zh) * 1995-02-27 2008-03-19 吉里德科学公司 新颖化合物,其合成方法及治疗用途
ES2249863T3 (es) 1995-02-27 2006-04-01 Gilead Sciences, Inc. Inhibidores selectivos de neuraminidasa viral o bacteriana.
CA2188835C (en) * 1995-02-27 2006-08-08 Norbert W. Bischofberger Novel compounds and methods for synthesis and therapy
AU4259500A (en) * 1995-02-27 2000-08-31 Gilead Sciences, Inc. Novel compounds and methods for synthesis and therapy
US5602277A (en) * 1995-03-30 1997-02-11 Biocryst Pharmaceuticals, Inc. Substituted benzene derivatives useful as neuraminidase inhibitors
US5714509A (en) * 1995-05-03 1998-02-03 The University Of Alabama Inhibitors of bacterial sialidase and methods of making and using the same
CN1184473A (zh) * 1995-05-19 1998-06-10 比奥塔科学管理有限公司 6－羟基酰胺－二氢吡喃衍生物
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
JPH0967270A (ja) * 1995-08-31 1997-03-11 Res Dev Corp Of Japan 水晶体混濁の予防および治療法、並びにそのための薬 剤
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
CA2245680C (en) * 1996-03-01 2005-09-27 Biota Scientific Management Pty. Ltd. Method of detection of influenza virus and compounds for use therein
US6093816A (en) 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
US6451766B1 (en) 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
PT823428E (pt) * 1996-07-22 2002-04-29 Sankyo Co Derivados do acido neuraminico sua preparacao e sua utilizacao em medicina
ES2198002T3 (es) * 1996-08-13 2004-01-16 Sankyo Company, Limited Compuestos de acido neuraminico.
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
US5859284A (en) 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
WO1998011083A1 (en) * 1996-09-10 1998-03-19 Daikin Industries, Ltd. 4-substituted-2,7-dideoxy-7-fluoro-2,3-didehydrosialic acids
US5719020A (en) * 1996-09-25 1998-02-17 Oklahoma Medical Research Foundation 4,7-dialkoxy N-acetylneuraminic acid derivatives and methods for detection of influenza type A and B viruses in clinical specimens
US5994377A (en) * 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
CA2268756A1 (en) * 1996-10-21 1998-04-30 Gilead Sciences, Inc. Piperidine compounds
AP9901531A0 (en) * 1996-11-14 1999-05-13 Biota Scient Management Pty Ltd Method and novel compounds for use therein.
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
JP3390965B2 (ja) 1997-09-12 2003-03-31 理化学研究所 糖結合スフィンゴシンを含有するポリマー化合物
EP1015417A1 (en) * 1997-09-17 2000-07-05 Gilead Sciences, Inc. Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
US20040053999A1 (en) * 1997-09-17 2004-03-18 Bischofberger Norbert W. Novel compounds and methods for synthesis and therapy
US20030129146A1 (en) * 1997-10-31 2003-07-10 Vincent Fischetti The use of bacterial phage associated lysing proteins for treating bacterial dental caries
TW480247B (en) * 1997-12-12 2002-03-21 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
WO1999054290A1 (en) * 1998-04-23 1999-10-28 Abbott Laboratories Inhibitors of neuraminidases
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
BR9912062A (pt) 1998-07-15 2001-04-03 Hassan Jomaa Compostos orgânicos fosforosos e seu uso
US6303764B1 (en) 1998-09-24 2001-10-16 Zymetx, Inc. Synthesis of 4,7-dialkyl chromogenic glycosides of N-acetylneuraminic acids
US6664235B1 (en) 1999-08-20 2003-12-16 Riken Medicaments comprising sialic acid derivatives as active ingredients
US6420552B1 (en) 1999-09-10 2002-07-16 Zymetx, Inc. Syntheses of 4-alkyl chromogenic glycosides and 7-alkyl chromogenic glycosides of N-acetylneuraminic acids
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
AU2039301A (en) * 1999-10-19 2001-04-30 Abbott Laboratories Neuraminidase inhibitors
US6627396B1 (en) 1999-10-28 2003-09-30 The Regents Of The University Of California Influenza sensor
SE9904289D0 (sv) * 1999-11-26 1999-11-26 Niklas Arnberg Method and camposition for the treatment of adenovairal ocular infections
US6733743B2 (en) 2000-03-06 2004-05-11 University Of Kentucky Research Foundation Methods to impair hematologic cancer progenitor cells and compounds related thereto
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
CA2459040A1 (en) * 2001-09-14 2003-03-27 Mimeon, Inc. Methods of making glycolmolecules with enhanced activities and uses thereof
JP2006241024A (ja) * 2005-03-01 2006-09-14 Takashi Suzuki 新規シアル酸誘導体
TW200811098A (en) 2006-04-27 2008-03-01 Astrazeneca Ab Chemical compounds
CN100471848C (zh) * 2006-06-05 2009-03-25 中国医学科学院医药生物技术研究所 一组长链烷氧烷基取代唾液酸衍生物及其制备方法
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
JP5345073B2 (ja) 2007-01-23 2013-11-20 テラピコン エス．アール．エル． 抗ウイルス化合物
US20080194801A1 (en) * 2007-02-14 2008-08-14 Swanson Basil I Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
US7981930B2 (en) * 2007-03-13 2011-07-19 Adamas Pharmaceuticals, Inc. Compositions and kits for treating influenza
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
RU2009141965A (ru) 2007-04-16 2011-05-27 Момента Фармасьютикалз, Инк. (Us) Определенные продукты гликопротеина и способы их производства
AU2008292859C1 (en) * 2007-08-31 2014-03-06 Academia Sinica Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity
WO2009129305A2 (en) 2008-04-15 2009-10-22 Tsrl, Inc. Prodrugs of neuraminidase inhibitors
DK2318832T3 (da) 2008-07-15 2014-01-20 Academia Sinica Glycan-arrays på PTFE-lignende aluminiumcoatede objektglas og relaterede fremgangsmåder
ES2507492T3 (es) 2008-11-28 2014-10-15 Cipla Limited Proceso para preparar zanamivir e intermedios para uso en el proceso
TWI491416B (zh) 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
EP2228054A1 (en) 2009-03-13 2010-09-15 ITALFARMACO S.p.A. Riluzole aqueous suspensions
CA2760106C (en) * 2009-05-04 2020-03-10 National Research Council Of Canada Inhibitors of sialidase or sialidase-like enzymes
NZ610978A (en) 2009-05-15 2014-11-28 Redx Pharma Ltd Redox drug derivatives
CN102471361B (zh) * 2009-07-15 2016-06-01 不列颠哥伦比亚大学 作为神经氨酸酶抑制剂的2,3-氟化糖苷及其作为抗病毒药物的用途
AU2010273184B2 (en) * 2009-07-16 2015-07-09 Griffith University Anti -influenza agents
IT1396620B1 (it) 2009-11-25 2012-12-14 Therapicon Srl Analoghi chimerici
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
JP2011136964A (ja) * 2009-12-28 2011-07-14 Gifu Univ ノイラミン酸誘導体、シアリダーゼ活性阻害剤及び抗インフルエンザ薬
US9921210B2 (en) 2010-04-07 2018-03-20 Momenta Pharmaceuticals, Inc. High mannose glycans
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
EP2568976B1 (en) * 2010-05-10 2015-09-30 Academia Sinica Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses
CN101921251B (zh) * 2010-09-21 2011-10-05 仙居县圃瑞药业有限公司 扎那米韦中间体的精制工艺方法
CN102464640A (zh) * 2010-10-29 2012-05-23 江苏正大天晴药业股份有限公司 扎那米韦的制备方法
AT510585B1 (de) 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
US20140073804A1 (en) 2011-02-24 2014-03-13 Ganpat Dan Shimbhu CHARAN Process for the preparation of zanamivir
US9170249B2 (en) 2011-03-12 2015-10-27 Momenta Pharmaceuticals, Inc. N-acetylhexosamine-containing N-glycans in glycoprotein products
WO2012142492A2 (en) * 2011-04-15 2012-10-18 University Of Georgia Research Foundation, Inc. Methods for inhibiting virus replication
KR101369584B1 (ko) 2011-04-19 2014-03-06 일양약품주식회사 페닐-이속사졸 유도체 및 그의 제조방법
GB2498080A (en) 2011-12-21 2013-07-03 Redx Pharma Ltd Derivatives of oseltamivir
US9637465B2 (en) 2012-01-19 2017-05-02 The University Of British Columbia 3′ Equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-virals
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
EP2856159A4 (en) 2012-06-01 2016-04-13 Momenta Pharmaceuticals Inc METHODS RELATING TO DENOSUMAB
EP4397768A3 (en) 2012-07-26 2024-12-18 Momenta Pharmaceuticals, Inc. Glycoproteins with anti-inflammatory properties
AU2013306098A1 (en) 2012-08-18 2015-02-12 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
CA2889903C (en) 2012-10-29 2021-03-09 Manjinder Singh Phull Antiviral phosphonate analogues and process for preparation thereof
WO2014149067A1 (en) 2013-03-15 2014-09-25 Momenta Pharmaceuticals, Inc. Methods related to ctla4-fc fusion proteins
EP2996772B1 (en) 2013-05-13 2018-12-19 Momenta Pharmaceuticals, Inc. Methods for the treatment of neurodegeneration
WO2014210397A1 (en) 2013-06-26 2014-12-31 Academia Sinica Rm2 antigens and use thereof
EP3013347B1 (en) 2013-06-27 2019-12-11 Academia Sinica Glycan conjugates and use thereof
CN103396957B (zh) * 2013-07-11 2015-08-19 中国海洋大学 一种来源于鲤链霉菌的海洋微生物多糖及其制备方法
EP3041484B1 (en) 2013-09-06 2021-03-03 Academia Sinica Human inkt cell activation using glycolipids with altered glycosyl groups
CN111116567B (zh) * 2013-09-09 2023-10-10 中国科学院上海有机化学研究所 扎那米韦和拉那米韦的中间体及其合成方法
EP3058084A4 (en) 2013-10-16 2017-07-05 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
JP6453050B2 (ja) * 2013-11-15 2019-01-16 国立大学法人富山大学 ２−デオキシ−２，３−ジデヒドロシアル酸誘導体およびその製造法
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
US10023892B2 (en) 2014-05-27 2018-07-17 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
AU2015206370A1 (en) 2014-01-16 2016-07-07 Academia Sinica Compositions and methods for treatment and detection of cancers
WO2015148915A1 (en) 2014-03-27 2015-10-01 Academia Sinica Reactive labelling compounds and uses thereof
KR20170003673A (ko) 2014-05-12 2017-01-09 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 감염성 질환을 치료하기 위한 다니릭신을 포함하는 약제 조성물
US20150344585A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-cd20 glycoantibodies and uses thereof
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
JP7062361B2 (ja) 2014-05-27 2022-05-06 アカデミア シニカ 抗ｈｅｒ２糖操作抗体群およびその使用
CN106714829A (zh) 2014-05-28 2017-05-24 中央研究院 抗TNF‑α醣抗体及其用途
NL2013420B1 (en) * 2014-09-05 2016-09-27 Univ Griffith Antiviral agents and uses thereof.
TWI745275B (zh) 2014-09-08 2021-11-11 中央研究院 使用醣脂激活人類ｉＮＫＴ細胞
WO2016063969A1 (ja) 2014-10-24 2016-04-28 ペプチドリーム株式会社 ヘマグルチニン結合ペプチド
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
WO2016118191A1 (en) 2015-01-24 2016-07-28 Academia Sinica Novel glycan conjugates and methods of use thereof
WO2017156192A1 (en) 2016-03-08 2017-09-14 Academia Sinica Methods for modular synthesis of n-glycans and arrays thereof
TWI764917B (zh) 2016-08-22 2022-05-21 醣基生醫股份有限公司 抗體、結合片段及使用方法
CN106520864A (zh) * 2016-09-28 2017-03-22 南京农业大学 一种酶法合成唾液酸类似物的方法及其应用
EP3630740A4 (en) * 2017-05-25 2021-03-31 The Governors of the University of Alberta METHOD OF PREVENTION OR TREATMENT OF ATHEROSCLEROSIS WITH INHIBITORS OF SPECIFIC ISOENZYMS OF HUMAN NEURAMINIDASES
WO2021209563A1 (en) 2020-04-16 2021-10-21 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
CA3238128A1 (en) 2021-12-23 2023-06-29 Subintro Limited Novel antiviral compositions comprising oleic acid
US20230310474A1 (en) * 2022-02-11 2023-10-05 Cleveland State University Coronavirus treatment composition and method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE627295A (cs) 1962-01-18

Also Published As

Publication number Publication date
DE19975068I2 (de) 2002-10-10
CS114591A3 (en) 1991-12-17
UA41252C2 (uk) 2001-09-17
SG43170A1 (en) 1997-10-17
HUT61989A (en) 1993-03-29
ZA913086B (en) 1992-12-30
JP2944750B2 (ja) 1999-09-06
DE69133604D1 (de) 2008-10-09
AU7533891A (en) 1991-12-12
PT97460A (pt) 1992-01-31
CZ288492B6 (en) 2001-06-13
PT97460B (pt) 1999-01-29
KR0169496B1 (ko) 1999-01-15
DE69128469T2 (de) 1998-06-04
HU219355B (en) 2001-03-28
CN1057260A (zh) 1991-12-25
SI9110745A (en) 1997-04-30
EP0526543A1 (en) 1993-02-10
NL990030I1 (nl) 1999-12-01
LU90468I2 (fr) 2000-01-03
JPH05507068A (ja) 1993-10-14
EP0786458B1 (en) 2008-08-27
AU654815B2 (en) 1994-11-24
PL166918B1 (pl) 1995-07-31
CY2186B1 (en) 2002-11-08
NO923944D0 (no) 1992-10-09
NO974670L (no) 1992-12-18
NO302751B1 (no) 1998-04-20
IE980526A1 (en) 2003-10-15
DE69128469D1 (de) 1998-01-29
PL167630B1 (pl) 1995-10-31
RU2119487C1 (ru) 1998-09-27
DK0526543T3 (da) 1998-08-24
YU48741B (sh) 1999-09-27
EP0786458A2 (en) 1997-07-30
HK1003834A1 (en) 1998-11-06
CN1091594C (zh) 2002-10-02
DE19975068I1 (de) 2000-01-13
FI924790A0 (fi) 1992-10-22
AU7759091A (en) 1991-11-11
ATE161253T1 (de) 1998-01-15
CA2081356A1 (en) 1991-10-25
CN1143853C (zh) 2004-03-31
OA09679A (en) 1993-05-15
ATE406358T1 (de) 2008-09-15
US5648379A (en) 1997-07-15
EP0526543B1 (en) 1997-12-17
FI20001231L (fi) 2000-05-23
FI924790L (fi) 1992-10-22
US5360817A (en) 1994-11-01
HU9203180D0 (en) 1992-12-28
MY107843A (en) 1996-06-29
BG62092B1 (bg) 1999-02-26
CA2291994A1 (en) 1991-10-25
NZ237936A (en) 1997-08-22
AP9100253A0 (en) 1991-04-30
CA2291994C (en) 2003-10-14
CA2081356C (en) 2000-02-22
CN1150020A (zh) 1997-05-21
PL167192B1 (pl) 1995-08-31
WO1991016320A1 (en) 1991-10-31
CN1036849C (zh) 1997-12-31
CN1184108A (zh) 1998-06-10
ES2313730T3 (es) 2009-03-01
YU74591A (sh) 1994-06-24
EP0526543A4 (en) 1993-04-21
NO974670D0 (no) 1997-10-09
AP249A (en) 1993-03-17
SI9110745B (en) 2001-06-30
NL990030I2 (nl) 2000-02-01
FI105478B (fi) 2000-08-31
FI20001231A7 (fi) 2000-05-23
HK1010191A1 (en) 1999-06-17
BG96978A (bg) 1993-12-24
IE911372A1 (en) 1991-11-06
HU210717A9 (en) 1995-06-28
GR3026225T3 (en) 1998-05-29
SK282950B6 (sk) 2003-01-09
EP0786458A3 (en) 1999-10-13
ES2113881T3 (es) 1998-05-16
NO1999021I1 (no) 1999-09-17
NO923944L (no) 1992-12-18

Similar Documents

Publication Publication Date Title
AU654815B2 (en) Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid and their use as antiviral agents
HK1003834B (en) Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
EP0539204B1 (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro derivatives of alpha D-neuraminic acid
WO1995020583A1 (en) Derivatives of 2-deoxy-2,3-dehydro-n-acetylneuraminic acid (dana)
US5990156A (en) 6-Carboxamido dihydropyran derivatives
WO1995018800A1 (en) Derivatives of 2-deoxy-2,3-dehydro-n-acetylneuraminic acid (dana)
US5639786A (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of α-D-neuraninic acid
WO1996004265A1 (en) 2,6-DIDEOXY-2,3-DIDEHYDRO-6-THIO DERIVATIVES OF α-D-NEURAMINIC ACID
JP3923081B6 (ja) ウイルスノイラミニダーゼ阻害剤としてのジヒドロピラン誘導体
JP3923081B2 (ja) ウイルスノイラミニダーゼ阻害剤としてのジヒドロピラン誘導体
HK1015137B (en) Antiviral 4-substituted-2-deoxy-2, 3-didehydro derivatives of alpha d-neuraminic acid

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
PEL Intention of commissioner to extend period of protection
EXTG Extension of patent term granted
KB Patent renewed
EXTN Extension order renewed
EXTN Extension order renewed